Faced with intense investor backlash, Unilever now says $68B is its final offer for GSK consumer healthcare business
In an anti-climatic end to a budding takeover fight, Unilever has all but given up on a buyout of GlaxoSmithKline’s consumer healthcare business.
Unilever, the consumer product giant behind household brands like Ben & Jerry’s, Lipton and Vaseline, said in a statement late Wednesday that it will not increase its offer above £50 billion ($68 billion) — which GSK had revealed days ago as its third and latest offer.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.